The report provides a detailed analysis essential for establishing an Enalapril production plant. It encompasses all critical aspects necessary for Enalapril production, including the cost of Enalapril production, Enalapril plant cost, Enalapril production costs, and the overall Enalapril production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Enalapril production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Enalapril is an FDA-approved prodrug that belongs to the class of angiotensin-converting enzyme (ACE) inhibitor drugs. It is extensively utilized as a medicine for the treatment and management of Hypertension (High Blood Pressure) due to its vasoconstricting properties. Moreover, it also finds its application in the treatment of congestive heart failure and asymptomatic left ventricular dysfunction by improving blood flow. Additionally, it is often utilized in the management of complications associated with diabetic nephropathy in diabetic patients.
The market for Enalapril is primarily driven due to its employment as an antihypertensive agent for managing high blood pressure, which significantly increases its demand in the pharmaceutical industry. Moreover, its usage in the treatment of heart failure and decreasing the symptoms associated with it further enhances its market expansion. Furthermore, the cost of raw materials (2-oxo-4-phenylbutanoate, etc.), availability and pricing, compliance with medical regulations, and maintaining quality standards are some of the factors that greatly influence industrial Enalapril procurement globally.
Raw Material for Enalapril Production
According to the Enalapril production plant project report, the major raw materials for Enalapril production include α-Alanyl-α-Proline-2-Oxo-4-phenylbutanoate.
Production Process of Enalapril
The extensive Enalapril production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: This method of production is initiated by the reaction of the benzyl ester of L-alanyl-L-proline with the ethyl ester of 3-benzoylacrylic acid to form an intermediate, which, on reduction, gives enalapril as the product. The process is initiated by the reaction of α-alanyl-α-proline and ethyl 2-oxo-4-phenylbutanoate, followed by the reduction of the obtained product by using Raney nickel catalyst, which results in the synthesis of enalapril as the final product.
Enalapril is a dicarboxylic acid monoester that serves as a prodrug with antihypertensive activity. The molecular formula of the compound is C20H28N2O5, and its molar mass is 376.4 g/mol. Moreover, this drug is available in the form of intravenous formulations for injection, and oral tablets. The boiling point of the compound is 582.4°C, and its melting point is 142-147. It is stored at 2-8°C in an inert atmosphere. The compound appears in the form of a powder that is soluble in DMSO and in water at 25mg/ml. The value of its dissociation constant is pka = 2.97, and its density is 1.204g/cm3. The chemical name of the compound is (S)-1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-proline.
